Home » Newsletters » BioWorld

BioWorld

Oct. 20, 1993

View Archived Issues

INSITE VISION COMPLETES IPO

IMMUNOMEDICS' AGENT IDENTIFIES INFECTIONS

FORMER GLAXO PRESIDENT TO HEAD GENVEC

GENENTECH INVESTS IN SCIENCE EDUCATION

IMMUNOTHERAPEUTICS FILES IND

CANTAB RAISES $21M IN BRITISH IPO

AGOURON ENTERS PROTEASE INHIBITOR FIELD

LAWRENCE LIVERMORE PURSUES MALE CONTRACEPTIVE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...